Navigation Links
Attain OTW Model 4194 Bi-Polar

ProductsAttain OTW Model 4194 Bi-Polar
Company Medtronic Inc.
Item Attain OTW Model 4194 Bi-Polar
Features 
  • Angled distal end designed for steerability and stable fixation in range of veins
  • Steroid eluting designed to minimize threshold peaking
  • Exclusive tip seal designed to minimize blood ingress to the lead body, and designed to facilitate repositioning and chronic lead management
  • Over the wire or stylet delivery to target pacing site
  • Bi-ipolar,6.2 Fr.
  • IS-1 connector
Description The Attain 4194 Bipolar over-the-wire left-heart lead is for use with cardiac resynchronization systems. This new steroid-eluting lead has an angled shape and can be inserted using either a guidewire or a stylet delivery method, giving physicians an extra option to successfully maneuver and position the lead in a variety of difficult venous anatomies. The Attain 4194 lead is the fourth generation of left-heart leads designed for use with the Medtronic InSync family of cardiac resynchronization therapy (CRT) pacemaker and defibrillator systems.
Info Medtronic Inc.
Customer Service: (800) 551-5544
Web site: http://www.medtronic.com/

Related medicine products :

1. Attain Venogram Balloon Catheter
2. Attain LV Leads
3. Attain CS Leads
4. Attain™ OTW Left-heart Lead
5. Attain™ Deflectable Catheter Delivery System
6. Attain Left Heart Delivery System
7. Attain Prevail™ Steerable Catheter Left-Heart Lead Delivery System
8. Attain Access Left Heart Delivery System
9. Reliance Stool, Model 5346
10. Reliance Stools, Model 5340
11. Reliance Stool, Model 5356
Gently curved shaft with 2 mm platform ideal for performing capsulorhexis through a tunnel incision. Flat handle with dull finish....
Straight shafts with 4 mm platform. Wide serrated handle with dull finish. Platform straight....
Straight shafts 4 mm platform. Wide serrated handle with dull finish. Platform angled 45 degrees....
Straight shafts with rounded tips. Smooth handle with dull finish....
Medicine Products:
(Date:1/19/2017)... ... January 19, 2017 , ... Wells ... facility enhancement of their 503A compounding pharmacy located in Ocala, Florida. , ... physicians and patients throughout the United States for high-quality human anti-aging and ...
(Date:1/19/2017)... ... January 19, 2017 , ... This month, the CEO and ... name of their drug rehab center in Delray Beach, Florida has been changed from ... only stars such as Philip Seymour Hoffman and Chris Farley are dying from heroin ...
(Date:1/19/2017)... , ... January 19, 2017 , ... WhoHaha , ... up with the American Heart Association (AHA) to produce a three-part video series that ... will debut as part of the launch of AHA’s Healthy For Good™ movement, which ...
(Date:1/19/2017)... ... January 19, 2017 , ... Cosmetic Town, an online ... procedures in order to make it easier for their readers to get the information ... they impact as well as the techniques used on those particular areas. , “We ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... and development solutions for drugs, biologics and consumer health products, today announced that ... with Gattefossé, the leader in innovative excipients and drug delivery solutions to health ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Calif. , Jan. 19, 2017  Abaxis, Inc. ... manufacturing point-of-care blood analysis instruments and consumables for the ... call to discuss its financial results for the third ... call will be at 4:15 p.m. ET on Thursday, ... for the third quarter fiscal year 2017 after the ...
(Date:1/19/2017)... , Jan. 19, 2017  Sensus Healthcare, ... device company specializing in the treatment of non-melanoma ... keloids, with superficial radiation therapy, today announced that ... year 2016 financial results on Thursday, February 2, 2017 ... will hold a conference call with the investment ...
(Date:1/19/2017)... , January 19, 2017 ... announced that the U.S. Food and Drug Administration (FDA) ... a New Drug Application (NDA) for SHP465, a long-acting, ... as a potential once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). ... or around June 20, 2017, the designated Prescription Drug ...
Breaking Medicine Technology: